SNOA icon

Sonoma Pharmaceuticals
SNOA

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $159K invested in Sonoma Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$19K
2
+$3.51K
3
+$11

Top Sellers

1
-$72K
2
-$39K
3
-$17K
4
UBS Group
UBS Group
Switzerland
-$2.9K
5
Renaissance Technologies
Renaissance Technologies
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$83K
2
$41K
3
$19K
4
$9K
5
$3.28K
6
$3.22K
7
$560
8
$96
9
$73
10
$49
11
$35
12
$24
13
$11
14
–
15
–
16
–